Aeolus Pharmaceuticals, Inc. (AOLS)

USD 0.0

(0.0%)

Annual Balance Sheets

(In USD)
Breakdown 2023 2022 2021 2020 2019 2016
Total Assets - - - - - 4.16 Million
Total Current Assets - - - - - 4.13 Million
Cash And Short Term Investments - - - - - 3.15 Million
Cash and Cash Equivalents - - - - - 3.15 Million
Short Term Investments - - - - - -
Net Receivables - - - - - 750 Thousand
Inventory - - - - - -
Other Current Assets - - - - - 230 Thousand
Total Non-Current Assets - - - - - 32 Thousand
Net PPE - - - - - -
Good Will And Intangible Assets - - - - - -
Good Will - - - - - -
Intangible Assets - - - - - -
Long-Term Investments - - - - - 32 Thousand
Tax Assets - - - - - -
Other Non Current Assets - - - - - -
Other Assets - - - - - -
Total Liabilities - - - - - 972 Thousand
Total Current Liabilities - - - - - 972 Thousand
Account Payables - - - - - 972 Thousand
Tax Payables - - - - - -
Short Term Debt - - - - - -
Deferred Revenue - - - - - -
Other Current Liabilities - - - - - -
Total Non Current Liabilities - - - - - -
Long-Term Debt - - - - - -
Deferred Revenue Non Current - - - - - -
Deferred Tax Liabilities Non Current - - - - - -
Other Non Current Liabilities - - - - - -
Other Liabilities - - - - - -
Total Equity - - - - - 3.19 Million
Stock Holders Equity - - - - - 3.19 Million
Common Stock - - - - - 1.52 Million
Retained Earnings - - - - - -190.18 Million
Accumulated other comprehensive income - - - - - -
Common Stock Equity - - - - - 3.19 Million
Capital Lease Obligation - - - - - -
Total Investments - - - - - 32 Thousand
Total Debt - - - - - -
Net Debt - - - - - -3.15 Million

Balance Sheet Charts